Lykos Therapeutics
MAPS PBC catalyzes healing and well-being through psychedelic drug development, therapist training programs, and sales of prescription psychedelics prioritizing public benefit above profit.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD618—927m (Dealroom.co estimates Jan 2024.)
Remote Oregon (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $100m | Series A | |
| Total Funding | AUD155m | ||